Clinical Trials Browser

Has results × Protein Subunit Vaccines × Dermatologic × Clear all

NCT02126579 2024-02-28

MEL60

Phase 1/2 Completed

50 enrolled 13 charts

Melanoma, Neoplasms

NCT00706992 2015-10-28

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Phase 2 Terminated

50 enrolled 13 charts

Melanoma